U.S. mobile Ebola labs should be up and running in Liberia this week.
Gut microbe in patients may tip doctors about the disease.
Genoscience Pharma, a company focused on discovering and developing small molecules to treat cancer by targeting cancer stem cells, announces that it will present data on its most promising candidate …
InterMune® is pleased to support the launch of a new European Patient Charter for people with idiopathic pulmonary fibrosis which is being presented in the European Parliament on 30th September …
EYEGUARD-US is a randomized withdrawal study, conducted at U.S. clinical sites, to determine the efficacy and safety of gevokizumab in treating Behçet's disease uveitis patients.
Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced the publication of two papers highlighting early studies of glembatumumab vedotin in breast cancer and metastatic melanoma in the Journal of …
Birt-Hogg-Dubé syndrome (BHD)
A blog dedicated to the bone cancer.
Copyright © 2006-2014 CheckOrphan. All rights reserved.
CheckOrphan is a 501(c)(3) nonprofit organization. Contributions to CheckOrphan in the United States and Switzerland are tax-exempt to the extent provided by law.
Powered by GetReelHealth.com
Copyright © 2005-2014